Ensign Peak Advisors, Inc
Position in NBIX — Neurocrine Biosciences Inc
CIK 1454984
SALT LAKE CITY, UT
Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,653,938
+$5,745,632 QoQ
Shares Held
175,946
-3.0% QoQ
Ownership
0.173%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#91
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $86,377,339 across 19 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (34.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
This page
|
175,946 | $29,653,938 | |
| 2 | ALKS |
Alkermes plc.
|
335,208 | $17,564,899 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
26,450 | $14,331,403 | |
| 4 | ZTS |
Zoetis Inc.
|
126,706 | $9,105,093 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
305,441 | $5,485,720 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
141,698 | $3,473,017 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
95,081 | $2,339,943 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
40,850 | $1,383,998 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,653,938 | 175,946 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,908,306 | 181,481 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,729,151 | 167,307 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $25,328,903 | 180,431 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $21,465,715 | 170,783 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $21,538,686 | 194,744 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $23,709,231 | 173,694 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $20,144,488 | 174,835 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $37,530,631 | 272,613 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,337,741 | 154,711 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $9,566,830 | 72,608 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,587,362 | 85,221 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,038,937 | 95,853 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,925,472 | 68,420 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,247,309 | 52,305 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,719,866 | 44,439 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,992,583 | 61,475 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $6,186,562 | 65,990 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $6,119,634 | 71,852 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,258,245 | 106,957 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $10,635,032 | 109,279 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,734,032 | 48,679 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $16,731,384 | 174,558 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $20,006,953 | 208,059 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $16,066,058 | 131,689 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $8,040,495 | 92,900 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||